Cargando…
Saving the hand: Role of multimodality therapy for Ewing's sarcoma family tumor of the palm
Autores principales: | Joseph, Sanjay A., Bhandari, Rahul, Albert, Ashley, Jackson, James, Kanakamedala, Madhava, Hamilton, Robert D., Barr, Jennifer, Vijayakumar, Srinivasan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000164/ https://www.ncbi.nlm.nih.gov/pubmed/29904746 http://dx.doi.org/10.1016/j.adro.2018.01.005 |
Ejemplares similares
-
Atrial Thrombus Mimicking Ewing's Sarcoma
por: Hon, Matthew, et al.
Publicado: (2019) -
Anlotinib, Vincristine, and Irinotecan for Advanced Ewing Sarcoma After Failure of Standard Multimodal Therapy: A Two‐Cohort, Phase Ib/II Trial
por: Xu, Jie, et al.
Publicado: (2021) -
Emerging Trends in Immunotherapy for Adult Sarcomas
por: Husain, Marium, et al.
Publicado: (2023) -
Sarcoma European and Latin American Network (SELNET) Recommendations on Prioritization in Sarcoma Care During the COVID‐19 Pandemic
por: Martin‐Broto, Javier, et al.
Publicado: (2020) -
Histiocytic and Dendritic Cell Sarcomas of Hematopoietic Origin Share Targetable Genomic Alterations Distinct from Follicular Dendritic Cell Sarcoma
por: Massoth, Lucas R., et al.
Publicado: (2021)